JA
John Aballi sold $270K of XGN stock
John Aballi, President and CEO of Exagen Inc. (XGN), sold 34,294 shares of XGN stock worth $270K, per an SEC Form 4 filed Oct 19, 2026.
It was an open-market sale.
The trade happened on Oct 16, 2026, 3 days before it was made public.
XGN has moved -46.5% since the trade date, from $7.72 to $4.13 (Nov 13, 2026 close).
- Traded
- Oct 16, 2026
- Disclosed
- Oct 19, 2026
- Filing delay
- 3 days
- Price since
- -46.5%
- Role
- President and CEO
- Source
- SEC Form 4